VIVA CREATIVE
agency: McCann HumanCare
brand: Viagra
client: Pfizer
photo clockwise from left: Doug Welch, SVP, executive creative director • Henry Schneider, VP, associate creative director • George Capuano, VP, associate creative director • Eric Bet, VP, associate creative director • Simon Hunter, SVP, group account director • Erica Yahr-Rader, SVP, group director, strategic planning • BJ Kaplan, SVP, executive creative director
Who would have thought Elvis's classic "Viva Las Vegas" would be used to market an ED drug? Well, if the drug in question is Viagra—a classic in the pharma world—the two are a match made in rock ?n' roll heaven. The television ad features a group of middle-aged men in a bar singing "Viva Viagra." "The ad is irreverent, and it colors outside the lines," says McCann's Doug Welch. "We wanted to make an ad that's celebratory and full of energy and life. The idea of a group of buddies who jam every week in a roadhouse in an unashamed, unembarrassed way destigmatizes the whole ED category."
The music was originally supposed to be used in the background of stories. To bring the ad to life, the agency decided to make the music the focus of the ad. Instead of a commercial, the spot comes across as more of a music video. Rather than create a campaign that tells people how miserable it is to suffer from ED, the Viagra ad inspires them to take action. By dramatizing the sense of life the band gets through Viagra, it acts as an inspiration for the target audience to travel the same journey.
PREVIOUS AGENCY ‹‹ HOME ›› NEXT AGENCY
Key Findings of the NIAGARA and HIMALAYA Trials
November 8th 2024In this episode of the Pharmaceutical Executive podcast, Shubh Goel, head of immuno-oncology, gastrointestinal tumors, US oncology business unit, AstraZeneca, discusses the findings of the NIAGARA trial in bladder cancer and the significance of the five-year overall survival data from the HIMALAYA trial, particularly the long-term efficacy of the STRIDE regimen for unresectable liver cancer.
Fake Weight Loss Drugs: Growing Threat to Consumer Health
October 25th 2024In this episode of the Pharmaceutical Executive podcast, UpScriptHealth's Peter Ax, Founder and CEO, and George Jones, Chief Operations Officer, discuss the issue of counterfeit weight loss drugs, the potential health risks associated with them, increasing access to legitimate weight loss medications and more.